4th Quarter - Report

ARENTFOX SCHIFF LLP for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

Proposed approaches to USDA and FDA regulation for oversight of biotechnology-derived animals Proposed approaches to the regulation of biotechnology-derived plant and microbe products by USDA, EPA, and FDA

LobbyistCovered position, as disclosed
STANLEY H ABRAMSON —
KAREN ELLIS CARR —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.